Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04680013 · ClinicalTrials.gov registry record
Genetic Studies in Familial Dementia
A clinical trial of Mild Cognitive Impairment and Dementia, sponsored by University of Miami.
- Completed
- Registry status
- 4,884
- Enrollment target
- 1
- Study location
NCT04680013: Completed study of Mild Cognitive Impairment and Dementia, sponsored by University of Miami.
NCT04680013 is a study of Mild Cognitive Impairment and Dementia that has completed, run by University of Miami. The registered enrollment target is 4,884 participants, above the 1,247-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (292% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04680013, a study of Mild Cognitive Impairment and Dementia, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- 4,884 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify genetic factors that contribute to or cause dementia (loss of memory) and related disorders across all ages and ethnic groups. This includes a number of neurological diseases such as early and late-onset Alzheimer disease, mild cognitive impairment, and other dementias.
Primary Outcome
Genetic factors will be measured through genome-wide genotyping arrays and/or whole-genome sequencing, and then correlated with Alzheimer disease and related phenotypes, such as cognitive impairment, functional impairment, and relevant biomarkers. .
Conditions Studied
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,884 participants |
| Start Date | 2007-06-01 |
| Est. Completion | 2024-10-29 |
What the finished NCT04680013 record still lists
NCT04680013 is an observational study that tracks outcomes without assigning an intervention. Its 4,884 participants enrollment target places it among the larger protocols in the corpus, above the 1,247-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (292% higher).
The record links to 5 conditions, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 0 interventions.
NCT04680013 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT04680013 about?
NCT04680013 is a clinical study titled "Genetic Studies in Familial Dementia". The purpose of this study is to identify genetic factors that contribute to or cause dementia (loss of memory) and related disorders across all ages and ethnic groups. This includes a number of neurological diseases such as early and late-onset Alzheimer disease, mild cognitive impairment, and other...
What is the current status of trial NCT04680013?
This trial is currently completed. The enrollment target is 4,884 participants. The study started on 2007-06-01. Estimated completion is 2024-10-29.
What conditions does trial NCT04680013 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment, Dementia, Alzheimer Disease, Early Onset, Dementia of Alzheimer Type, Alzheimer Disease, Late Onset.
Who is sponsoring clinical trial NCT04680013?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04680013 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04680013's enrollment target sits among peer trials
4,884 5th of 205 higher than 201 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
RECRUITING · Early Phase 1
-
MCI Speech in Noise
RECRUITING
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05252754 · 4,874 participants · Phase 3
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
- NCT05929976 · 4,900 participants
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
- NCT01719055 · 4,800 participants
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
- NCT05485675 · 4,800 participants · NA
Stand & Move at Work II: Effectiveness and Implementation of a Worksite Wellness Program
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI